voriconazole

E556657

Voriconazole is a broad-spectrum triazole antifungal medication commonly used to treat serious invasive fungal infections, particularly those caused by Aspergillus species.

Try in SPARQL Jump to: Statements Referenced by

Statements (48)

Predicate Object
instanceOf azole antifungal
broad-spectrum antifungal agent
triazole antifungal drug
affectsPathway ergosterol biosynthesis
hasAdministrationForm intravenous solution
oral suspension
tablet
hasATCCode J02AC03
hasBrandName Vfend NERFINISHED
hasChemicalClass triazole
hasCommonAdverseEffect elevated liver enzymes
photosensitivity
rash
visual disturbances
hasContraindication coadministration with certain CYP3A4 substrates that prolong QT interval
hasDrugInteraction CYP3A4 inducers
CYP3A4 inhibitors
carbamazepine
phenytoin NERFINISHED
rifampin
hasEffect disruption of fungal cell membrane formation
hasMechanismOfAction inhibition of fungal cytochrome P450–dependent 14α-sterol demethylase
hasPharmacokineticsProperty high oral bioavailability
nonlinear pharmacokinetics
hasPregnancyCategory D (US, historical classification)
hasRouteConsideration loading dose recommended for intravenous use
hasRouteOfAdministration intravenous
oral
hasSeriousAdverseEffect QT interval prolongation
hepatotoxicity
torsades de pointes
hasSpectrumOfActivity molds
yeasts
hasTargetOrganism Aspergillus species NERFINISHED
Candida species NERFINISHED
inhibits lanosterol 14α-demethylase
isDerivedFrom fluconazole analogue
isIndicatedFor immunocompromised patients with invasive fungal infections
isMetabolizedBy CYP2C19 NERFINISHED
CYP2C9 NERFINISHED
CYP3A4 NERFINISHED
treats Fusarium infections
Scedosporium infections
candidemia
esophageal candidiasis
invasive aspergillosis
invasive fungal infections
wasApprovedBy U.S. Food and Drug Administration NERFINISHED

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Aspergillus fumigatus treatedWith voriconazole